A group of lawmakers are arguing that forcing drugmakers to explain their reason for charging so much for drugs could lead to major reforms in lowering prices.

That is why two bipartisan senators and a House member on Tuesday introduced the FAIR Drug Pricing Act. The bill would require drugmakers to disclose and provide more information on planned price hikes, including detailing research and development costs.